Sarepta Therapeutics: Discretion Is the Better Part of Valor
November 25 2015 - 11:05AM
The Motley Fool
http://www.fool.com/investing/general/2015/11/25/sarepta-therapeutics-discretion-is-the-better-part.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024